arrow
S

Sanju Sinha

Sanford Burnham Prebys Medical Discovery Institute
H指数:21
被引数:1,612

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The microenvironment dictates glyco-immune surveillance via HSF1-mediated metabolism

微环境通过HSF1介导的代谢调控糖免疫监视

2026-08-070
OA
DeepTarget predicts anti-cancer mechanisms of action of small molecules by integrating drug and genetic screens

DeepTarget通过整合药物和基因筛选来预测小分子的抗肿瘤作用机制。

2025-11-050
OAAI
Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells

通过整合免疫细胞、基质细胞和肿瘤细胞的去卷积表达模式,增强对乳腺癌患者化疗反应的预测

2025-10-300
PRE
Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

低GPX4通过可靶向的适应性FSP1上调,驱动三阴性乳腺癌中持续的药物耐受持久状态。

2025-09-110
OAAI
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor types

CDS1与CDS2之间的合成致死相互作用是葡萄膜黑色素瘤以及多种肿瘤类型的易损性。

2025-07-040
OAAI
Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues

绘制原发性和转移性癌症与其起源和靶向正常组织的转录组图

2024-12-060
OAAI
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

一种深度学习框架,通过转录组学预测组织病理学图像的癌症治疗反应

2024-07-035
OA
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

PERCEPTION使用肿瘤的单细胞转录组学预测患者对治疗的反应和抵抗力

2024-04-188
OA
The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
2023-06-1223
PRE